FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288096496> ?p ?o ?g. }

• W4288096496 endingPage "3238" @default.
• W4288096496 startingPage "3230" @default.
• W4288096496 abstract "Abstract Background Given associations with serious cognitive and physical adverse effects (e.g., dementia, falls), strong anticholinergics, like urinary antimuscarinics (UAMs), should be avoided in older adults. This feasibility study aimed to (1) evaluate the implementation rate of pharmacists' recommendations intended to de‐escalate UAMs, (2) quantify the change in overall anticholinergic dosing exposure from these recommendations, and (3) investigate factors that predict recommendation implementation. Methods This was a retrospective, observational, before‐and‐after study. Pharmacists ( n = 18) devised strategies to de‐escalate UAMs in 187 participants (mean age 72.4 ± 9.4; 77.0% female; mean number of medications 12.9 ± 4.6) of 35 Programs of All‐Inclusive Care for the Elderly (PACE). PACE prescribers (non‐physicians and physicians) determined whether to implement recommendations. Implementation was defined as a change in the prescription records consistent with the pharmacist's recommendation at 2‐, 4‐, 6‐, and 9‐months post‐recommendation. Anticholinergic dosing exposure was measured at each time point using standardized daily doses (SDD). Multivariable logistic regression was used to identify factors that predicted recommendation implementation. Results Across 9 months, recommendations were implemented in 118 out of 187 participants, yielding a 63.1% implementation rate. Of these, 77.1% ( n = 91/118) implemented by month 2. Implementers' mean overall anticholinergic SDD decreased 65.4% from baseline (baseline: 2.6 [95% CI: 2.2, 3.0] to month 9: 0.9 [95% CI: 0.6,1.2], p < 0.001) whereas non‐implementers demonstrated no significant change ( p = 0.52). Taking <10 baseline medications (OR 2.75; 95% CI: 1.09, 7.61); baseline UAM SDD ≥2 (OR 2.20; 95% CI: 1.11, 4.44); uncomplicated recommendations (OR 3.38; 95% CI: 1.67–7.03); and baseline calcium channel blocker use (OR 2.19; 95% CI: 1.09, 4.52) predicted implementation. Conclusion Our high implementation rate indicates that pharmacists' recommendations to de‐escalate UAMs as a way to reduce overall anticholinergic exposure is feasible in medically complex, community‐dwelling older adults. Future research should investigate whether these recommendations benefit cognitive (e.g., delirium, dementia) and/or physical functioning (e.g., falls)." @default.
• W4288096496 created "2022-07-28" @default.
• W4288096496 creator A5010528905 @default.
• W4288096496 creator A5027964499 @default.
• W4288096496 creator A5037434877 @default.
• W4288096496 creator A5037692851 @default.
• W4288096496 creator A5043455924 @default.
• W4288096496 creator A5080359453 @default.
• W4288096496 date "2022-07-28" @default.
• W4288096496 modified "2023-10-01" @default.
• W4288096496 title "Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly" @default.
• W4288096496 cites W1493332517 @default.
• W4288096496 cites W1512373410 @default.
• W4288096496 cites W1892357160 @default.
• W4288096496 cites W2071052332 @default.
• W4288096496 cites W2107996856 @default.
• W4288096496 cites W2146314584 @default.
• W4288096496 cites W2147463647 @default.
• W4288096496 cites W2162173660 @default.
• W4288096496 cites W2168499550 @default.
• W4288096496 cites W2326735434 @default.
• W4288096496 cites W2340507627 @default.
• W4288096496 cites W2542627378 @default.
• W4288096496 cites W2620353619 @default.
• W4288096496 cites W2733089542 @default.
• W4288096496 cites W2767154997 @default.
• W4288096496 cites W2790423233 @default.
• W4288096496 cites W2795111036 @default.
• W4288096496 cites W2884077652 @default.
• W4288096496 cites W2887215077 @default.
• W4288096496 cites W2887753976 @default.
• W4288096496 cites W2944264319 @default.
• W4288096496 cites W2982360465 @default.
• W4288096496 cites W3007510371 @default.
• W4288096496 cites W3042309695 @default.
• W4288096496 cites W3049432632 @default.
• W4288096496 cites W3081916435 @default.
• W4288096496 cites W4213351464 @default.
• W4288096496 cites W4241984066 @default.
• W4288096496 cites W4288096496 @default.
• W4288096496 cites W43306833 @default.
• W4288096496 doi "https://doi.org/10.1111/jgs.17965" @default.
• W4288096496 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35900034" @default.
• W4288096496 hasPublicationYear "2022" @default.
• W4288096496 type Work @default.
• W4288096496 citedByCount "5" @default.
• W4288096496 countsByYear W42880964962022 @default.
• W4288096496 countsByYear W42880964962023 @default.
• W4288096496 crossrefType "journal-article" @default.
• W4288096496 hasAuthorship W4288096496A5010528905 @default.
• W4288096496 hasAuthorship W4288096496A5027964499 @default.
• W4288096496 hasAuthorship W4288096496A5037434877 @default.
• W4288096496 hasAuthorship W4288096496A5037692851 @default.
• W4288096496 hasAuthorship W4288096496A5043455924 @default.
• W4288096496 hasAuthorship W4288096496A5080359453 @default.
• W4288096496 hasBestOaLocation W42880964962 @default.
• W4288096496 hasConcept C104863432 @default.
• W4288096496 hasConcept C118552586 @default.
• W4288096496 hasConcept C126322002 @default.
• W4288096496 hasConcept C142724271 @default.
• W4288096496 hasConcept C151956035 @default.
• W4288096496 hasConcept C159110408 @default.
• W4288096496 hasConcept C167135981 @default.
• W4288096496 hasConcept C194828623 @default.
• W4288096496 hasConcept C197934379 @default.
• W4288096496 hasConcept C204787440 @default.
• W4288096496 hasConcept C23131810 @default.
• W4288096496 hasConcept C2426938 @default.
• W4288096496 hasConcept C27415008 @default.
• W4288096496 hasConcept C2777288759 @default.
• W4288096496 hasConcept C2778689640 @default.
• W4288096496 hasConcept C2778941218 @default.
• W4288096496 hasConcept C2779134260 @default.
• W4288096496 hasConcept C2779457091 @default.
• W4288096496 hasConcept C2779483572 @default.
• W4288096496 hasConcept C36434225 @default.
• W4288096496 hasConcept C512399662 @default.
• W4288096496 hasConcept C53875530 @default.
• W4288096496 hasConcept C54183767 @default.
• W4288096496 hasConcept C71924100 @default.
• W4288096496 hasConceptScore W4288096496C104863432 @default.
• W4288096496 hasConceptScore W4288096496C118552586 @default.
• W4288096496 hasConceptScore W4288096496C126322002 @default.
• W4288096496 hasConceptScore W4288096496C142724271 @default.
• W4288096496 hasConceptScore W4288096496C151956035 @default.
• W4288096496 hasConceptScore W4288096496C159110408 @default.
• W4288096496 hasConceptScore W4288096496C167135981 @default.
• W4288096496 hasConceptScore W4288096496C194828623 @default.
• W4288096496 hasConceptScore W4288096496C197934379 @default.
• W4288096496 hasConceptScore W4288096496C204787440 @default.
• W4288096496 hasConceptScore W4288096496C23131810 @default.
• W4288096496 hasConceptScore W4288096496C2426938 @default.
• W4288096496 hasConceptScore W4288096496C27415008 @default.
• W4288096496 hasConceptScore W4288096496C2777288759 @default.
• W4288096496 hasConceptScore W4288096496C2778689640 @default.
• W4288096496 hasConceptScore W4288096496C2778941218 @default.
• W4288096496 hasConceptScore W4288096496C2779134260 @default.
• W4288096496 hasConceptScore W4288096496C2779457091 @default.

• next